Posts Tagged ‘medical marijuana’

Researchers have found regular and occasional cannabis use as a teen is associated with a greater risk of other illicit drug taking in early adulthood. The study also found cannabis use was associated with harmful drinking and smoking.

Source: Teen cannabis use and illicit drug use in early adulthood linked: One in 5 adolescents at risk of tobacco dependency, harmful alcohol consumption and illicit drug use — ScienceDaily

It is amazing that this garbage gets published.  It would be akin to “Blind Kids less likely to see as adults”.  What is the CAUSALITY?  This paper would lead naive readers to think that teen cannabis use causes illicit drug use in adults.  But, how about teens who hang with the wrong crowds, who have lack of parental involvement, who may be flunking classes, who may have lower IQs, who may be struggling in school, who may disregard laws and prudence and use illicit cannabis and other drugs as teens as well as other illicit drugs later in life?

Time and time again, follow-up studies disprove the implications when CAUSALITY is considered.  More often than not, socio-economic conditions and IQ’s are the underlying causal factors which drive various conditions mistakenly attributed to cannabis.

AuntieBS

Low levels tetrahydrocannabinol, or THC, the main psychoactive compound in marijuana, does reduce stress, but in a highly dose-dependent manner, new research confirms.

Source: Low-dose THC can relieve stress; more does just the opposite — ScienceDaily

 

It should also be pointed out that experience with cannabis plays a role in anxiety reduction.  An inexperienced user may experience paranoia and increased anxiety at a much lower dose than an experienced user.

AuntieBS

NORML’s mission is to move public opinion sufficiently to legalize the responsible use of marijuana by adults, and to serve as an advocate for consumers to assure they have access to high quality marijuana that is safe, convenient and affordable.

Source: Congress Reauthorizes Protections For State Medical Cannabis Programs – NORML.org – Working to Reform Marijuana Laws

Memory performance decreases with increasing age. Cannabis can reverse these ageing processes in the brain. This was shown in mice by scientists at the University of Bonn with their colleagues at The Hebrew University of Jerusalem (Israel). Old animals were able to regress to the state of two-month-old mice with a prolonged low-dose treatment with a cannabis active ingredient. This opens up new options, for instance, when it comes to treating dementia.

Source: Cannabis reverses aging processes in the brain, study suggests: Researchers restore the memory performance of Methuselah mice to a juvenile stage — ScienceDaily

The DEA must be upset.  Clearly, they ignore all the scientific evidence and pursue their own job-preserving ways, while they ruin people’s lives and stifle research.  And, Congress knows this (or are complete idiots) but has their lips firmly on Big Parma’s butt cheeks.  (Sigh)  When will we ever emerge from the dark ages?

AuntieBS

Source: The National District Attorneys Association Is Lying About Marijuana | NORML Blog, Marijuana Law Reform

 

What bullshit!  These assholes have nothing better to do than chase stoners, and people who use cannabis for medical purposes.  My almost non-existent esteem of lawyers has dipped to a new low.

AuntieBS

Addict Behav. 2017 Apr 4;72:138-143. doi: 10.1016/j.addbeh.2017.04.006. [Epub ahead of print]

Source: Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis. – PubMed – NCBI

Cannabis use is associated with reduced prevalence of obesity and diabetes mellitus (DM) in humans and mouse disease models. Obesity and DM are a well-established independent risk factor for non-alcoholic fatty liver disease (NAFLD), the most prevalent liver disease globally. The effects of cannabis use on NAFLD prevalence in humans remains ill-defined. Our objective is to determine the relationship between cannabis use and the prevalence of NAFLD in humans. We conducted a population-based case-control study of 5,950,391 patients using the 2014 Healthcare Cost and Utilization Project (HCUP), Nationwide Inpatient Survey (NIS) discharge records of patients 18 years and older. After identifying patients with NAFLD (1% of all patients), we next identified three exposure groups: non-cannabis users (98.04%), non-dependent cannabis users (1.74%), and dependent cannabis users (0.22%). We adjusted for potential demographics and patient related confounders and used multivariate logistic regression (SAS 9.4) to determine the odds of developing NAFLD with respects to cannabis use. Our findings revealed that cannabis users (dependent and non-dependent) showed significantly lower NAFLD prevalence compared to non-users (AOR: 0.82[0.76–0.88]; p<0.0001). The prevalence of NAFLD was 15% lower in non-dependent users (AOR: 0.85[0.79–0.92]; p<0.0001) and 52% lower in dependent users (AOR: 0.49[0.36–0.65]; p<0.0001). Among cannabis users, dependent patients had 43% significantly lower prevalence of NAFLD compared to non-dependent patients (AOR: 0.57[0.42–0.77]; p<0.0001). Our observations suggest that cannabis use is associated with lower prevalence of NAFLD in patients. These novel findings suggest additional molecular mechanistic studies to explore the potential role of cannabis use in NAFLD development.

Source: Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study